申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US05616717A1
公开(公告)日:1997-04-01
Racemic mixtures of 1-(S,R)-(2-pyridyl)-2-cyclohexylethylamine are separated into (+)-(S)-1-(2-pyridyl)-2-cyclohexylethylamine or (-)-(R)-1-(2-pyridyl)-2-cyclohexylethylamine by admixture with (+)- or (-)-3-bromocamphor-8-sulfonic acid. 1-(S)-(2-pyridyl)-2-cyclohexylethylamine is an intermediate in the preparation of leukotriene biosynthesis inhibitors.
1-(S,R)-(2-吡啶基)-2-环己基乙基胺的外消旋混合物通过与(+)-或(-)-3-溴松香酸混合分离为(+)-(S)-1-(2-吡啶基)-2-环己基乙基胺或(-)-(R)-1-(2-吡啶基)-2-环己基乙基胺。1-(S)-(2-吡啶基)-2-环己基乙基胺是制备白三烯生物合成抑制剂的中间体。